The German pharma giant wants to do a bit of ‘rebranding,’ after the mega merger with the U.S.-based agro-giant. But anti-Monsanto sentiment is bound to remain no matter what it’s called.
The German pharma giant wants to do a bit of ‘rebranding,’ after the mega merger with the U.S.-based agro-giant. But anti-Monsanto sentiment is bound to remain no matter what it’s called.